Pressure BioSciences, Inc.

PBIO · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$81$4$132$19
Short-Term Investments$0$0$0$0
Receivables$151$295$155$131
Inventory$305$686$1,148$593
Other Curr. Assets$223$258$423$315
Total Curr. Assets$760$1,243$1,857$1,057
Property Plant & Equip (Net)$228$385$511$238
Goodwill$0$0$0$0
Intangibles$0$317$404$490
Long-Term Investments$62$64$60$517
Tax Assets$0-$63,638$975$0
Other NC Assets$0$63,638-$975$0
Total NC Assets$290$766$975$1,245
Other Assets$0$0$0$0
Total Assets$1,050$2,010$2,832$2,303
Liabilities
Payables$1,320$637$528$772
Short-Term Debt$22,663$20,240$14,230$8,912
Tax Payable$0$0$0$0
Deferred Revenue$234$58$37$47
Other Curr. Liab.$9,358$13,469$9,831$8,786
Total Curr. Liab.$33,576$34,404$24,625$18,518
LT Debt$223$290$413$683
Deferred Rev, NC$5$2$4$19
Deferred Tax Liab, NC$0$0$0-$19
Other NC Liab.$0$0$0$19
Total NC Liab.$227$292$416$703
Other Liabilities$0$0$0$0
Cap. Leases$128$282$396$221
Total Liabilities$33,804$34,696$25,041$19,220
Equity
Pref Stock$0$1$1$1
Common Stock$354$137$91$42
Retained Earnings-$169,029-$133,826-$118,277-$96,466
AOCI$35,684$31,996$31,715$29,192
Other Equity$100,237$69,006$64,261$50,313
Total Equity-$32,754-$32,686-$22,209-$16,918
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,050$2,010$2,832$2,303
Net Debt$22,805$20,526$14,510$9,577